Gerard van de Weerd

Gerard van de Weerd

Auto-generated profile, based on publicly available information

Gerard van de Weerd

Institute for Translational Vaccinology, P.O. Box 450, 3720 AL Bilthoven, Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DODinja Oosterhoff
Dinja Oosterhoff
GWGerard van de Weerd
Gerard van de Weerd
GEGerco van Eikenhorst
Gerco van Eikenhorst
TGTanja D. de Gruijl
Tanja D. de Gruijl
LPLeo A. van der Pol
Leo A. van der Pol
WBWilfried A. M. Bakker
Wilfried A. M. Bakker
Viral vaccines can be produced in adherent or in suspension cells. The objective of this work was to screen human suspension cell lines for the capacity to support viral replication. As the first step, it was investigated whether poliovirus can replicate in such cell lines. Sabin poliovirus type 1 was serially passaged on five human cell lines, HL60, K562, KG1, THP-1, and U937. Sabin type 1 was capable of efficiently replicating in three cell lines (K562, KG1, and U937), yielding high viral titers after replication. Expression of CD155, the poliovirus receptor, did not explain susceptibility to replication, since all cell lines expressed CD155. Furthermore, we showed that passaged virus replicated more efficiently than parental virus in KG1 cells, yielding higher virus titers in the supernatant early after infection. Infection of cell lines at an MOI of 0.01 resulted in high viral titers in the supernatant at day 4. Infection of K562 with passaged Sabin type 1 in a bioreactor system yielded high viral titers in the supernatant. Altogether, these data suggest that K562, KG1, and U937 cell lines are useful for propagation of poliovirus.